Carregando...
Folinic acid in colorectal cancer: esquire or fellow knight? Real-world results from a mono institutional, retrospective study
The stock of therapeutic weapons available in metastatic colorectal cancer (mCRC) has been progressively grown over the years, with improving both survival and patients' clinical outcome: notwithstanding advances in the knowledge of mCRC biology, as well as advances in treatment, fluoropyrimidi...
Na minha lista:
Publicado no: | Oncotarget |
---|---|
Principais autores: | , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Impact Journals LLC
2021
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7869580/ https://ncbi.nlm.nih.gov/pubmed/33613849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27872 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|